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Abstract
Background: Palytoxin and, likely, its analogues produced by the dinoflagellate genus Ostreopsis, represent a class of non-
proteinaceous compounds displaying high toxicity in animals. Owing to the wide distribution and the poisonous effects of
these toxins in humans, their chemistry and mechanism of action have generated a growing scientific interest. Depending
on the exposure route, palytoxin and its Ostreopsis analogues may cause several adverse effects on human health, including
acute inflammatory reactions which seem more typical of cutaneous and inhalation contact. These observations have led us
to hypothesize that these toxins may activate pro-inflammatory signalling cascades.
Methodology and Principal Findings: Here we demonstrate that palytoxin and a semi-purified Ostreopsis cf. ovata toxin
extract obtained from a cultured strain isolated in the NW Adriatic Sea and containing a putative palytoxin and all the
ovatoxins so far known – including the recently identified ovatoxin-f – significantly increase the levels of mRNAs encoding
inflammation-related proteins in immune cells, i.e. monocyte-derived human macrophages, as assessed by Real-Time PCR
analysis. Western immunoblot and electrophoretic mobility shift assays revealed that nuclear transcription factor -kB (NF-
kB) is activated in cells exposed to toxins in coincidence with reduced levels of the inhibitory protein IkB-a. Moreover,
Mitogen-Activated Protein Kinases (MAPK) were phosphorylated in response to palytoxin, as also reported by others, and to
the Ostreopsis toxin extract, as shown here for the first time. By using specific chemical inhibitors, the involvement of NF-kB
and p38 MAPK in the toxin-induced transcription and accumulation of Cycloxigenase-2, Tumor Necrosis Factor-a, and
Interleukin-8 transcripts has been demonstrated.
Conclusions and Significance: The identification of specific molecular targets of palytoxin and its Ostreopsis analogues,
besides contributing to expand the still limited knowledge of the intracellular signalling cascades affected by these toxins,
may have important implications in setting up focused pharmacological interventions, replacing currently used
symptomatic treatments.
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Introduction
Palytoxin (PLTX) is a potent non-protein marine toxin isolated
in 1971 from Palythoa, a soft coral of the Pacific Ocean [1]–??[3].
Since then, PLTX and a number of palytoxin analogues have been
extracted from many other marine organisms, including those
belonging to the dinoflagellate genus Ostreopsis [4]. Ostreopsis species
are important components of the tropical and subtropical reef
environments, however, recently they have spread to temperate
waters. In the last few years, massive blooms of Ostreopsis cf. ovata
(O. cf. ovata), represented by the genotype of the Atlantic/
Mediteranean clade [5], have been observed along the Mediter-
ranean coasts [6]–??[8]. High resolution liquid chromatography-
mass spectrometry (HR LC-MS) studies disclosed the presence,
both in field and cultured O. cf. ovata cells, of putative PLTX [9]
and six new palytoxin congeners, named ovatoxins (OVTX),
namely OVTX-a [10], OVTX-b, -c, -d + -e and -f [11], [12].
Palytoxin and its analogues may enter the food chain and
accumulate mainly in fishes and crabs, causing severe human
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38139intoxication and death following ingestion of contaminated
products [13], [14]. Furthermore, toxic effects in individuals
exposed via inhalation or skin contact to marine aerosol in
coincidence with Ostreopsis blooms, have been reported [15], [16].
Thus, the formerly unsuspected broad distribution of the benthic
dinoflagellate Ostreopsis spp. has recently posed a problem of risk
assessment for human health [17], [18].
At the cellular level, the Na
+/K
+–ATPase is the primary
molecular target of PLTX. To this regard, the ability of palytoxin
to bind the Na
+/K
+–ATPase and convert it into a non-selective
ion channel, has been widely demonstrated in various experimen-
tal systems [19], [20]. The transformation of the Na
+/K
+–ATPase
into a cation channel is associated with a series of secondary
effects, including disruption of the ion equilibrium, increased Na
+
permeability, membrane depolarization and consequent Ca
2+
influx that may lead to multiple events regulated by Ca
2+-
dependent pathways [21]. Depending on the cell type and toxin
dose, filamentous actin (F-actin) disassembly, cell rounding and
swelling, and cell death, have been described [22]–??[24].
Palytoxin has also been demonstrated to act as a non-TPA (12-
O-tetradecanoylphorbol-13 acetate)-type skin tumor promoter,
being able to modulate key signal transduction pathways involved
in carcinogenesis [25], [26]. In particular, it has been shown that
PLTX stimulates prostaglandin production from arachidonic acid
[27] and activates MAPKs (Mitogen-Activated Protein Kinases),
including extracellular signal-regulated kinase (ERK), c-Jun N-
terminal kinase (JNK) and p38 MAPK [28]. MAPKs are a family
of serine/threonine kinases that mediate intracellular signaling
associated with a variety of cellular activities such as cell
proliferation, differentiation, survival, death, and transformation
[29]. Mitogenic agents typically activate ERK, while p38 and JNK
signaling pathways are activated by inflammatory cytokines or in
response to cellular stresses such as genotoxic, osmotic, hypoxic or
oxidative stress. Once activated, MAPKs can phosphorylate
various protein substrates, including transcription factors, and
thereby modulate gene expression. Unfortunately, as far as
palytoxin is concerned, the knowledge of the biochemical
pathways by which MAPKs activation is transmitted to down-
stream effectors and nuclear targets and translated into biological
outcomes is still limited. Most of the studies concerning this aspect
have been performed by Wattemberg’s research group which is
interested in PLTX as tool to probe the role of different types of
signalling mechanisms in carcinogenesis [28]. On the other hand,
a deeper understanding of the mechanisms of action and of the
signal transduction cascades affected by PLTX and its derivatives
would help to better interpret the effects observed in subjects
coming into contact with these biotoxins and to set up rational
pharmacological interventions to limit or avoid systemic adverse
reactions. Interestingly, a febrile-respiratory syndrome has been
observed in individuals exposed to O. cf. ovata bloom aerosols; the
symptoms included rhinorrhea, cough, fever and asthma-like
illness (reviewed in [18]). In addition, PLTX application to the
skin caused a severe irritative reaction, involving inflammation,
edema and necrosis in animals [30]. Cases of dermal toxicity
(edema erythema, urticarial rush, pruritus) have also been
documented in humans exposed to marine water containing O.
cf. ovata cells or in patients who have handled zoanthid corals [31].
On the whole, these observations strongly suggest that PLTX and
its congener toxins may actively engage and modulate pro-
inflammatory signaling pathways, leading to production of
inflammatory mediators in immune cells.
In this study, we provide the very first evidence that palytoxin is
able to increase the levels of mRNAs encoding inflammation-
related proteins in primary human macrophages through activa-
tion of p38 MAPK and transcription factor –kB (NF-kB).
Macrophages play a critical role in the initiation, maintenance,
and resolution of inflammation [32]. By synthesizing and secreting
a wide array of cytokines (including interleukins-1, -6, and tumor
necrosis factor), chemokines (including interleukin-8), and arachi-
donic metabolites, macrophages initiate inflammatory responses
and recruit activated neutrophils to the site of inflammation. NF-
kB is a well known transcription factor which plays a crucial role
in the transcriptional regulation of genes involved in controlling
cell survival and death, inflammation, and stress responses [33]. In
particular, the NF-kB pathway is considered a prototypical pro-
inflammatory signaling pathway, largely because of the role of NF-
kB in the expression of genes such as those encoding for cytokines,
chemokines and adhesion molecules [34].
Interestingly, the same effects produced at the molecular level
by PLTX were also observed when a semi-purified toxin extract,
obtained from cultured O. cf. ovata cells, was tested, suggesting that
toxins contained in the extract may have a biological activity
similar to that displayed by PLTX. Quali-quantitative composition
of ovatoxins depends on the O. cf. ovata strain: in most cases
OVTX-a, -b, -c, and –d + -e are synthesized by the alga [11],
[35]–??[37] and only very recently a strain producing all these
ovatoxins together with OVTX-f has been found [12]. This O. cf.
ovata strain, that is quite unique in that synthesizes all the ovatoxins
so far known, was used in this study. To the best of our knowledge,
this is the first attempt to gain insights into the mechanism of
action of Ostreopsis toxins.
Results
Toxin profile of the O. cf. ovata extract.
An extract obtained from O. cf. ovata CBA2-122, a strain
isolated in the north-western Adriatic Sea Ancona- Italy, was
subjected to a single clean-up step and used in this study. Further
purification was avoided in order to recover enough toxins to
perform in vitro studies. The semi-purified extract contained a
putative PLTX and all the ovatoxins so far known, namely
OVTX-a, -b, -c, -d + -e and -f [11], [12]. Ovatoxins have recently
been identified as palytoxin-like compounds based on a compar-
ison of their HR LC-MS data with those of palytoxin, namely i)





iii) elemental composition of fragment ions from the favored C-8
and C-9 cleavage dividing palytoxin-like molecules in two partial
structures A and B, respectively (Table 1 and Figure 1). Note that
herein we refer both in name and elemental composition to
ovatoxin-b, -c, -d + -e previously described by Ciminiello et al.
[11]. According to the reported HR LC-MS and MS
n data [10],
[11] i) OVTX-a presents the same A-moiety as PLTX and 2
oxygen atoms fewer (potentially 2 hydroxyl groups) in the B-
moiety; ii) OVTX-b presents C2H4O (potentially a hydroxyl and
two methylene groups) more than OVTX-a in the A moiety
whereas structure B is identical, at least in the elemental
composition; iii) OVTX-c presents C2H4O2 more than OVTX-
a. Compared to ovatoxin-a, it presents additional C2H4O atoms
(potentially a hydroxyl and two methylene groups) in the A moiety
and an extra oxygen atom (potentially a hydroxyl group) in the B
moiety; iv) OVTX-d and -e are isobaric compounds that present
one oxygen atom more than OVTX-a. OVTX-d presents the
same A moiety as OVTX-a and one additional oxygen atom
(potentially a hydroxyl group) in the B moiety, while OVTX-e
contains one more oxygen atom (potentially a hydroxyl group) in
the A moiety and the same B moiety as OVTX-a; v) ovatoxin-f
presents the same A-moiety as OVTX-a and C2H4 more than
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moiety. This last toxin has very recently been identified in the O.
cf. ovata strain used in this study and subjected to an in-depth HR
LC-MS
n study which allowed the restriction of the elemental
composition difference between OVTX-a and OVTX-f to the
region close to the B-side terminal [12].
Toxins contained in the semi-purified extract, (here referred to
as OSTRTX – Ostreopsis Toxins), were quantified as reported in
the experimental section. OSTRTX concentration in the Ancona
O. cf. ovata semi-purified extract was calculated to be 3.59 mg/ml.
Ovatoxin-f was the principal component of the toxin profile
(46.6%) followed by ovatoxin-a (21.7%), ovatoxin-b (19.5%),
ovatoxin-c (2.6%), ovatoxin-d + -e (8.4%) and putative palytoxin
(1.2%). Toxin profile is quite unique as it comprises all the
ovatoxins so far identified.
Increased levels of Cycloxygenase-2, Tumor Necrosis
Factor-a and Interleukin-8 mRNAs in monocyte-derived
human macrophages upon exposure to palytoxin and to
the OSTRTX extract
To test whether palytoxin and palytoxin-like compounds might
triggerapro-inflammatoryresponse,a commerciallyavailable PLTX
standardand the semi-purified toxin extract obtained from O.cf. ovata
CBA2-122 (both quantified by HR LC-MS) were administered to
monocyte-derived human macrophages and the mRNA level of
three<rpar;. Furthermore, since typical macrophage activators are
Figure 1. Structure of palytoxin. Cleavage between C-8 and C-9 occurs in HR LC-MS and MS
2 experiments and divides the molecule in two
moieties, A-side and B-side.
doi:10.1371/journal.pone.0038139.g001
Table 1. Most abundant ions of palytoxin and ovatoxins used in quantitative HR LC-MS analyses.
TOXIN Principal ions (m/z) Elemental formulae
name [M+2H-H2O]
2+ [M+H+Ca]
3+ M A side B side
palytoxin 1331.2417 906.4851 C129H223N3O54 C16H28N2O6 C113H195NO48
ovatoxin-a 1315.2480 895.8255 C129H223N3O52 C16H28N2O6 C113H195NO46
ovatoxin-b 1337.2595 910.4976 C131H227N3O53 C18H32N2O7 C113H195NO46
ovatoxin-c 1345.2566 915.8286 C131H227N3O54 C18H32N2O7 C113H195NO47
ovatoxin-d 1323.2439 901.1533 C129H223N3O53 C16H28N2O6 C113H195NO47
ovatoxin-e 1323.2439 901.1533 C129H223N3O53 C16H28N2O7 C113H195NO46
ovatoxin-f 1329.2606 905.1616 C131H227N3O52 C16H28N2O6 C115H199NO46
Molecular formulae (M) of each compound and elemental composition of their relevant A- and B-side fragments deriving from cleavage between C-8 and C-9 (see
Figure 1), as deduced by HR LC-MS and MS
2 experiments.
doi:10.1371/journal.pone.0038139.t001
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nants of research laboratory materials and reagents, PLTX stock
solutions and the OSTRTX extract were tested with a commercial
Limulus assay. This kind of test revealed that toxin preparations were
endotoxin-free, thus allowing the exclusion of the possibility that the
observed effects were due to bacterial contaminants rather than to the
marine biotoxins themselves.
Since mRNA accumulation is expected to result in protein
production, the levels of COX-2, TNF-a and IL-8 proteins were
monitored by western immunoblotting and immunoprecipitation
of the cytokines from the culture medium, using specific
Figure 2. COX-2, IL-8 and TNF-a mRNA levels in human macrophages exposed to PLTX and to the OSTRTX extract. Evaluation of COX-
2, IL-8 and TNF-a mRNA levels by quantitative Real-Time PCR assay. Total RNA, extracted from primary human macrophages exposed 4 h to PLTX
(2 ng/ml), to the O. cf. ovata toxin extract (final OSTRTX concentration 2 ng/ml and 20 ng/ml) or the vehicle (i.e. 0.05% MetOH), was amplified with
gene-specific primers. Expression data, normalized to the housekeeping B2M gene, were analyzed by the 2
2DDCT method and referred to the value
obtained in untreated cells (CTR). The boxplots show the results of 8 and 5 independent experiments performed with PLTX and the OSTRTX extract,
respectively. Asterisks indicate statistical significance versus cells receiving the vehicle alone (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0038139.g002
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a and IL-8 protein expression were unsuccessful. Indeed, no
proteins were detected in toxin-treated cells, neither at 4 h of
incubation, in coincidence of mRNA appearance, nor at later
incubation times (i.e. 8 h, 16 h and 24 h), when they are expected
to accumulate within cells or in the culture medium in sufficient
amounts to be revealed by conventional methods (data not shown).
By contrast, COX-2, TNF-a and IL-8 proteins were always
detectable in lipopolysaccharide-stimulated macrophages, used as
a positive control, thus demonstrating the efficacy of the
experimental approaches employed (data not shown).
However, it should be highlighted that while at 4 h incubation
cells underwent rounding, but were still metabolically active, as
assessed by MTS assay (Figure 3), 50% of the cell population died
within 8 h of exposure to both PLTX and OSTRTX and
conspicuous vacuoles appeared in the cytoplasm of residual
adherent cells (Figure 3). At 24 h, about 25% of the macrophages
were still alive, but most of them contained a big unique vacuole,
occupying almost the entire cell volume (Figure 3). This phenotype
is reminiscent of autophagic processes which usually precede or
accompany cell death [39], although further experiments will be
necessary to determine the exact mechanism.
It has been demonstrated that PLTX can act as a potent
translational inhibitor, being able to completely inhibit protein
synthesis in Rat-1 cells at a dose of 10 pM [40]. Thus, in light of
the finding that toxic effects occur very rapidly after exposure to
the toxins and that cells may become unable to efficiently translate
mRNAs into proteins, we concluded that the toxin doses used in
our study may not allow to demonstrate that mRNAs encoding for
COX-2, TNF-a and IL-8 are indeed translated into their
respective protein products.
PLTX and the OSTRTX extract lead to reduced IkB-a
protein levels and increased IkB-a mRNA, suggesting
that toxins may induce activation of NF-kB
NF-kB is a transcription factor which controls the expression of
numerous genes involved in immune and inflammatory responses.
The classical NF-kB complex is a heterodimer composed of the
p65/RelA and p50 subunits. NF-kB is retained in the cytoplasm of
most cells due to association with inhibitory proteins, called IkBs,
of which the most common is IkB-a. Upon cell stimulation, IkB-a
is phosphorylated, ubiquitinated and degraded within the cytosol
by the 26S proteasome complex, thus NF-kB subunits are released
and translocate to the nucleus where they turn on target gene
expression [41]. One of the first genes to be transcribed is that
encoding IkB-a itself [42]. Newly synthesized free IkB-a binds to
nuclear NF-kB leading to export of the complex into the
cytoplasm, thus allowing the establishment of a negative feedback
loop which controls NF-kB activation [43], [44]. In order to assess
the possibility that NF-kB may be activated by PLTX and the
OSTRTX extract, we monitored the levels of IkB-a mRNA in
cells receiving 4 h treatment with PLTX (2 ng/ml) or with the O.
cf. ovata toxin extract to a final OSTRTX concentration of 2 ng/
ml and 20 ng/ml. Since IkB-a gene promoter is indeed strictly
dependent on functional NF-kB, IkB-a mRNA induction repre-
sents a bona fide marker of NF-kB activation. Real-Time PCR
analysis revealed that IkB-a mRNA levels were significantly
increased over the basal level upon stimulation with 2 ng/ml
PLTX or 20 ng/ml OSTRTX, thus suggesting that NF-kBi s
activated by both toxin preparations (Figure 4). Although this
evidence demonstrates that, at 4 h incubation, IkB-a re-synthesis
had already occurred, IkB-a protein levels were still lower in
PLTX- and OSTRTX-treated cells than in cells receiving the
vehicle or ineffective doses of OSTRTX (i.e. 2 ng/ml), as assessed
by western immunoblot of whole cell lysates with a specific
antibody (Figure 5A, upper panel, compare lanes 3 and 4 with 1
and 2). As loading control, the blot was re-probed with an anti p65
antibody since, upon NF-kB activation, p65 redistributes within
intracellular compartments while the whole content does not
change. Accordingly, no differences in total p65 protein levels
were observed (Figure 5A, lower panel). Since protein extracts of
Figure 5A were obtained by lysing the cells in SDS (Sodium
Dodecyl Sulphate) buffer which allows to immediately boil the
sample and denature proteins, we excluded that reduced levels of
IkB-a could be the consequence of in vitro degradation processes.
On the whole, this demonstrates that toxins are presumably able to
activate NF-kB by reducing the levels of its inhibitory protein IkB-
a. Despite increased mRNA levels, the cellular content of IkB-a
protein remained low, probably for the same reason why we could
not detect COX-2, TNF-a and IL-8 proteins.
NF-kB p65 subunit is degraded in vitro by lysosomal
proteases the activity of which is inhibited in vivo by
PLTX and the OSTRTX extract
Since IkBa degradation leads to NF-kB nuclear translocation,
PLTX-, OSTRTX- or vehicle-treated cells were sub-fractionated
in order to obtain nuclear extracts to be tested in EMSA
(Electrophoretic Mobility Shift Assay). This type of assay, also
known as bandshift, is a rapid and sensitive method to detect and
quantify transcription factors in crude extracts, based on their
ability to bind DNA target sequences in vitro. Before setting up
bandshift assays, cytoplasmic-nuclear fractions were preliminary
subjected to western immunoblot analysis, using an antibody
specific for p65/RelA. Surprisingly, while p65 was detected in
whole lysates of vehicle-treated cells (Figure 5B, lane 1), obtained
by disrupting the cells directly in denaturing SDS buffer as in
Figure 5A, the immunoreactive band was almost undetectable in
cytosolic (Figure 5B, lane 3) and nuclear (Figure 5B, lane 5)
fractions, deriving from an extraction protocol in native condi-
tions. By contrast, p65 was clearly present in both compartments
of PLTX- (Figure 5B, lanes 4 and 6) and OSTRTX-treated cells
(data not shown) and the amount detected was consistent with the
levels determined in whole cell extracts (Figure 5B, lane 2). p65/
RelA has been found associated with the cytoskeleton [45] and
palytoxin is known to alter cytoskeletal dynamics [46]. Therefore,
we have hypothesized that, in vehicle-treated cells, p65 precipi-
tated in the insoluble fraction together with the cytoskeletal
structures. By contrast p65 was released in the soluble fraction in
cells receiving PLTX, due to the ability of the toxin to depolarize
actin fibers. To this end, the pellet obtained after nuclear protein
extraction, which should contain the cytoskeleton and which is
usually discarded, was solubilized in SDS-PAGE (Polyacrilamide
Gel Electrophoresis) sample buffer and submitted to western
immunoblotting analysis. As shown in figure 5B, again p65
content was lower in cells receiving the vehicle than in PLTX-
treated macrophages (compare lane 7 with 8). Based on these
observations, we concluded that p65 was not differently distributed
within the cell, but rather its levels were lower in control than in
toxin-treated cells. Indeed, during cytosolic extraction in native
conditions, active lysosomal proteases are released from lysosomes
and because they are not denatured, they are free to degrade
cytosolic and nuclear proteins. Interestingly, the activity of these
proteases was not neutralized by the commercial cocktail of
protease inhibitors used, but was apparently inhibited (directly or
indirectly) by PLTX and OSTRTX treatment. Thus, we first
checked whether PLTX addition to extraction buffers, in
particular that used to break cells and release the cytosolic content
(Buffer A), was sufficient to block in vitro protein degradation. To
Pro-Inflammatory Activity of Paly- and Ovatoxin
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tubes, and the cell pellets were extracted in an equal volume of
SDS buffer, Buffer A and Buffer A supplemented with 8 ng/ml
PLTX (a 4-fold excess with respect to the amount added in the
culture medium), respectively. The sample in SDS buffer was
immediately boiled and diluted with an equal volume of buffer A,
while the other two were incubated on ice for 30 min. At the end
of the incubation time, an equal volume of SDS sample buffer 26
was added to all tubes and the samples boiled in order to obtain
comparable protein patterns. Western blotting analysis of the
samples revealed that no differences in p65 protein levels were
found between macrophages extracted in Buffer A (Figure 5C,
lane 2) and Buffer A containing PLTX (Figure 5C, lane 3). In both
cases the amount of p65 was far lower than that detected in cells
lysed directly in SDS buffer (Figure 5C, compares lanes 2 and 3
with lane 1). From this experiment, we concluded that PLTX is
probably able to exert an inhibitory activity on lysosomal proteases
in vivo by an indirect mechanism. This aspect, although interesting
Figure 3. Macrophage morphology and viability after exposure to PLTX and to the OSTRTX extract. Optical images of macrophages
incubated 4 h, 8 h and 24 h with PLTX (2 ng/ml) and the O. cf. ovata toxin extract (final OSTRTX concentration 20 ng/ml) versus cells receiving the
vehicle alone (i.e. 0.05% MetOH). Pictures were taken with a magnification X 40 lens. Cell viability was measured at 4 h, 8 h and 24 h incubation with
the toxins by the MTS assay. All the values are referred to cells left untreated (CTR). The graph shows the results of at least 3 independent
experiments (6 S.E.M.).
doi:10.1371/journal.pone.0038139.g003
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the scope of the present study. By contrast, to continue our
analyses, it was necessary to inhibit p65 degradation during
extractions in native conditions in order to quantitatively compare
nuclear extracts obtained from vehicle-treated and PLTX/
OSTRTX-treated cells when submitted to EMSA.
It is well known that endosomes and lysosomes harbor serine,
cysteine and aspartic acid proteases. Thus, to block their activity, all
the extraction buffers were further supplemented with specific
chemical inhibitors such as leupeptin, pestatin, AEBSF [4-(2-
aminoethyl)-benzenesulfonyl fluoride] and MG-132. To test the
efficacy of the new protease inhibitor cocktail, we repeated the
experiment above by lysing the cells in SDS buffer, Buffer A and
Buffer A PLUS (i.e. Buffer A containing the commercial and the
new proteasome inhibitor cocktail). This buffer formulation was
effective in preventing p65 degradation as shown in Figure 5, panel
D, where it is possible to note that levels of p65 in cells lysed in
Buffer A PLUS (line 3) were significantly higher than those obtained
in Buffer A (line 2) and very similar to those detected by lysing cells
in SDS buffer (line 1). In this case as well, comparisons between
protein content were made possible by adding an equal volume of
Buffer A or SDS buffer to SDS or Buffer A/A PLUS lysates,
respectively. Based on the above results, EMSA experiments were
subsequently performed using nuclear extracts obtained by
supplementing all the extraction buffers with the new inhibitor
cocktail, as reported under ‘‘Materials and Methods’’.
PLTX and the OSTRTX extract induce NF-kB nuclear
translocation
Once established the conditions to prevent in vitro degradation
processes, nuclear extracts were prepared from macrophages
treated with the O. cf. ovata toxin extract at effective (20 ng/ml)
and ineffective (2 ng/ml) OSTRTX doses, as previously deter-
mined, and with palytoxin (2 ng/ml) for different lengths of time
up to 4 h. As control, cells were exposed 4 h to the vehicle.
Nuclear extracts were incubated with a double-stranded oligonu-
cleotides (Igk)-
32P-labelled containing the NF–kB consensus
sequence, and then submitted to native PAGE (Figure 6). NF-kB/
DNA complexes were detected by exposing the gel in a Molecular
Imager. The resulting image clearly shows that NF-kB translocates
into the nucleus of both OSTRTX- and PLTX-treated cells as
soon as 1 h after toxin addition to the culture medium, as
demonstrated by an increase in the signal of the retarded band
over the basal level (Figure 6, lanes 5–7 and 8–10). The highest
signal was obtained at 4 h (lanes 7 and 10). NF-kB nuclear
translocation was only slightly detectable in the nucleus of the cells
receiving the dose of OSTRTX which did not result in a
significant increase in the mRNA levels of inflammation-related
genes (Figure 6, lanes 2–4). Specificity of the assay was
demonstrated by disappearance of the signal when a 50-fold
excess of unlabelled Igk, but not of an unrelated ODN (YY1) was
included in the reaction mixture (Figure 6, lanes 11 and 12), before
adding the labeled probe. Supershift analysis revealed that toxin-
induced NF-kB complexes contained p65 and p50 subunits, as
demonstrated by up-shift of the signal following addition of specific
antibodies (Figure 6, lanes 13, 14). No shift was observed with an
antibody against an unrelated factor (YY1) (Figure 6, lane 15).
NF-kB and p38 MAPK signaling pathways are activated
by PLTX and the OSTRTX extract to increase the mRNA
levels of inflammation-related genes
To verify whether NF-kB activation was part of the molecular
mechanism(s) mediating PLTX- and OSTRTX-induced COX-2,
TNF-a and IL-8 mRNA expression and accumulation, cells were
pre-treated with andrographolide, a molecule able to interfere in
vivo with the binding of NF-kB to endogenous DNA consensus
sequences, and then incubated 4 h with the toxins.
Real-Time PCR analysis revealed that all the mRNAs analyzeds
were significantly down-regulated in cells pre-treated with
andrographolide as compared to cells left untreated and then
exposed to palytoxin (Figure 7). Similar results were obtained with
the OSTRTX extract (data not shown). IkB-a mRNA levels were
monitored as a positive control and found to be strongly down-
regulated as expected, based on the evidence that the IkB-a gene
is under the direct transcriptional control of NF-kB (Figure 7). By
contrast, UbC gene transcription, which is independent of NF-kB
activation ([47] and unpublished results), was up-regulated up to 2-
fold in toxin-treated cells as compared to the basal level (not
shown), but its expression was unaffected by andrographolide, thus
Figure 4. IkB-a mRNA levels in human macrophages exposed to PLTX and to the OSTRTX extract. Evaluation of IkB-a mRNA levels by
quantitative Real-Time PCR assay. Total RNA, extracted from primary human macrophages exposed 4 h to PLTX, to the O. cf. ovata toxin extract (final
OSTRTX concentration 2 ng/ml and 20 ng/ml) or to the vehicle (i.e. 0.05% MetOH), was amplified with IkB-a gene-specific primers. Expression data,
normalized to the housekeeping B2M gene, were analysed by the 2
2DDCT method and referred to the value obtained in untreated cells (CTR). The
boxplots show the results of 8 and 5 independent experiments performed with PLTX and the OSTRTX extract, respectively. Asterisks indicate
statistical significance versus cells receiving the vehicle alone (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0038139.g004
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(Figure 7).
At the moment, little is known about intracellular signaling
pathways modulated by PLTX and OSTRTX. Recent reports
have indicated that palytoxin transmits signals through Mitogen-
Activated Protein Kinases [28]. On the other hand, an important
mechanism by which inflammatory genes are up-regulated in
immune cells is through activation of MAPKs. Furthermore,
MAPKs may participate in the signal transduction cascade leading
to NF-kB activation [48], [49].
There is evidence that palytoxin-stimulated MAPK signalling
can differ depending on the cell type [50]. On the other hand,
most of the studies on PLTX toxicity have been performed using
cell lines and, to the best of our knowledge, never in primary
macrophages. Thus, based on these observations we wanted to
preliminarily investigate the effects of PLTX and of the OSTRTX
extract on MAPK activation in our cellular model. ERK activity
was measured by immunoblot analysis and an antibody that
specifically recognizes the dually phosphorylated active form of
ERK1/2 (Figure 8A). The phospho-ERK immunoblot revealed
that the kinases were already phosphorylated in whole cell extracts
of vehicle-treated cells and the levels of the phosphorylated forms
did not change upon cell exposure to PLTX or OSTRTX for 4 h
(Figure 8A, compare lane 1 with 2–4). Depending on the cell
donor, ERK phosphorylation appeared slightly down-regulated
following toxin administration in some analyses (data not shown).
A similar approach was used to test JNK and p38 MAPK activity.
In both cases, kinases resulted activated by phosphorylation
following incubation of the cells with PLTX or effective doses of
OSTRTX (20 ng/ml) (Fig. 8A, lanes 2–4). At 2 ng/ml, OSTRTX
only slightly affected the phosphorylation status of JNK p54 and
p38 MAPK.
To elucidate the possible relationship between toxin-induced
p38 MAPK and JNK activation and increased levels of
inflammation-associated gene transcripts in macrophages, we used
well known pharmacological blockers of kinase activity. Pre-
treatment of macrophages with 1 mM SB 202190, a selective p38
inhibitor, reduced PLTX -induced COX-2, TNF-a and IL-8
mRNA levels by about 70–80% (Figure 8B). No effects were
observed on IkB-a mRNA levels which directly relies on NF-kB
activation (Figure 8B). By contrast, 1 mM JNK inhibitor failed to
prevent or significantly decrease toxin-stimulated target gene
mRNA accumulation. The inhibitor was also ineffective when the
dose was raised to 5 mM (Figure 8B). Similar results were obtained
with 20 ng/ml OSTRTX (data not shown). Collectively, inhibitor
experiments indicate that p38 MAPK is involved, along with NF-
kB, in the signalling cascade mediating synthesis and accumula-
tion of transcripts encoding inflammation-related proteins.
Discussion
PLTX is known as one of the most toxic non proteinaceaous
compounds ever isolated. Depending on the exposure route,
palytoxin and its Ostreopsis analogues have been postulated to cause
several adverse effects on human health, including acute
inflammatory reactions which seem more typical of cutaneous
and inhalation contact (reviewed in [18]). In particular, subjects
exposed to marine water in coincidence with O. cf. ovata blooms
along the Italian, Spanish and French Mediteranean coasts, all
reported a clinical picture where the most prominent and common
symptoms were fever and irritative reactions of the upper and
lower respiratory tracts, conjunctiva and skin, variously associated
[18]. Significantly, when hospitalized, these patients benefited
from a symptomatic treatment which also included corticosteroids
Figure 5. IkBa and p65 protein levels in cells treated with the
vehicle, the OSTRTX extract and PLTX. (A)I kBa protein levels were
determined in whole cell lysates obtained from macrophages incubated
4 h with the vehicle (lane 1), the OSTRTX extract (lanes 2–3) or PLTX (lane
4). Protein extracts (15 mg) were resolved by SDS-PAGE on 8% gel and
then submitted to Western immunoblotting. Blots were probed with an
anti-IkBa (upper panel) and an anti-p65 (RelA) antibody to check for
protein loading (lower panel). (B) intracellular content and subcellular
distribution of p65 (RelA) in PLTX- versus vehicle-treated cells was
assessed by immunoblotting analysis of whole (15 mg, lanes 1–2),
cytosolic (15 mg, lanes 3–4) and nuclear (10 mg, lane 5–6) extracts. Whole
cell extracts were obtained by lysing cells in SDS buffer. In parallel, cells
were sub-fractionated by extraction in Buffer A (BUFF A, cytosolic
proteins) followed by Buffer B (nuclear proteins, BUFF B), the residual
material, containing insoluble proteins, including those associated with
cytoskeletal structures, was solubilized in SDS-PAGE sample buffer and
run in parallel (lanes 7–8). (C) Approaches to inhibit p65 in vitro
degradationduringextractioninnativeconditions.Cellpellets,containing
an equivalent number of macrophages, were lysed in SDS buffer (SDS
BUFF, lane 1), Buffer A (BUFF A, lane 2) or Buffer A supplemented with
palytoxin (BUFF A+PLTX, lane 3). An equal volume of SDS sample buffer
was added to all tubes and comparable volumes of the resulting protein
extracts were resolved by electrophoresis and immunoblotted with an
anti p65 antibody.(D) cell pellets as in C were lysed in SDS buffer (lane 1),
Buffer A (lane 2) and Buffer A further supplemented with lysososmal
protease inhibitors (BUFF A PLUS, lane3) and submitted to SDS-PAGE and
immunoblotting with an anti p65 antibody.
doi:10.1371/journal.pone.0038139.g005
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these evidences have led to hypothesize that PLTX and congener
toxins may indeed exert a pro-inflammatory activity. Although
several case reports ascribed to PLTX and ovatoxin exposure have
been characterized from a clinical point of view, the presence of
these toxins in the suspected causative specimen or targeted tissue
has not always been confirmed [18]. In addition, since the source
of contamination in vivo is obviously represented by complex
biological matrices, at present it cannot be excluded that cell
fragments and/or other chemical substances, other than palytoxin
and/or ovatoxins themselves, could be responsible for the
observed effects. Thus, this study was undertaken with the aim
to establish whether PLTX and, possibly, its congener toxins from
Ostreopsis cf. ovata, a species known to cause poisoning in the
Mediterranean area, may activate pro-inflammatory signalling
pathways in cells of the immune system. To this end, we have
tested commercially available purified PLTX and compared its
activity to that of a semi-purified toxin extract from O. cf. ovata cells
containing, other than 1.2% putative PLTX, all the ovatoxins so
far known (ovatoxin-a, -b, -c, -d, -e) and a new one, named
ovatoxin-f (Table 1). Among the various O. cf. ovata extracts so far
characterized [11], [35], [36], the toxin extract obtained from the
CBA2-122 clone was selected as it presented the most complete
ovatoxin profile, in that it contains all the ovatoxins so far known.
To the best of our knowledge, this is the first investigation which
attempts to gain information on the biological activity of ovatoxin.
Our data clearly demonstrate that in primary human macro-
phages, which represent the first line of defence at contact sites,
PLTX and the O. cf. ovata semi-purified toxin extract induce a
significant accumulation of gene transcripts, the products of which
are involved in inflammation (Figure 2). Selected targets consisted
of COX-2, TNF-a and IL-8. Cycloxigenase-2 catalyses the
conversion of arachidonic acid to prostaglandins, resulting in pain
and inflammation [51]. It has been previously demonstrated that
pM concentrations of palytoxin stimulate production of prosta-
glandins and that this event requires new protein synthesis [27],
[52]. However, these studies did not explore the nature of the
signalling pathway leading from palytoxin binding to arachidonic
acid metabolism. Thus, our evidence adds a new piece to the
puzzle, suggesting that PLTX-stimulated prostaglandin produc-
tion may occur as the consequence of PLTX-induced NF-kB and
p38 MAPK activation which leads to increased levels of COX-2
mRNA.
Similarly to COX-2 mRNA, the other targets analysed (i.e.
TNF-a and IL-8) resulted significantly up-regulated by PLTX as
compared to vehicle-treated cells (Figure 2). The accumulation of
transcripts encoding TNF-a and IL-8 in macrophages in response
to PLTX is in agreement with induction of an acute inflammatory
reaction. Indeed, TNF-a is a pro-inflammatory cytokine and
mediator of many immune functions which is produced during
acute phase reaction, particularly by activated macrophages [53].
IL-8 is a potent pro-inflammatory chemokine that can promote
Figure 6. NF-kB nuclear translocation in toxin-treated cells. Nuclear extracts were obtained from macrophages incubated with the O. cf. ovata
toxin extract (final OSTRTX concentration 2 ng/ml and 20 ng/ml) (lanes 2–7) or PLTX (2 ng/ml) (8–10) for different lengths of time (i.e. 1 h, 2 h and
4 h). Cells exposed to the vehicle 4 h were used as control (lane 1). Nuclear extracts (5 mg) were submitted to EMSA using a
32P-labeled ODN,
containing the NF-kB consensus sequence (Igk), as probe. Protein-DNA complexes were separated on 5% PAGE and then detected in a GS-250
Molecular Imager. Specificity of binding was assessed by competition experiments where nuclear extracts, from PLTX-treated cells, were pre-
incubated with a 50-fold excess of cold Igk probe (lane 11) or an ODN containing the consensus sequence of the unrelated factor YY1 (lane 12). For
supershift assay nuclear extracts were pre-incubated with antibodies against NF-kB p65 and p50 subunits (lanes 13, 14), while an antibody against
YY1 was used as control (lane 15).
doi:10.1371/journal.pone.0038139.g006
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tion [54]. Compared to PLTX, the OSTRTX extract, although at
a 10-fold higher toxin concentration, produced the same effect at
the molecular level (Figure 2), suggesting that ovatoxins may exert
a PLTX-like activity. Unfortunately, because the O. cf ovata toxin
extract was partially purified and it also contains a putative PLTX,
a direct correlation between ovatoxins and increased mRNA levels
of inflammation-related genes cannot be established at the
moment. However, on one hand, the very good overlap between
the effects observed in response to PLTX and to the O. cf. ovata
toxin extract and the similarity in the chemical structure between
ovatoxins and PLTX would exclude the involvement of other
contaminant substances which may be present in the extract. On
the other hand, the very high relative abundance of ovatoxins
(99% of OSTRTX) strongly suggests that OVTXs, rather than the
putative PLTX, may directly induce or at least contribute
significantly to the activity displayed by the OSTRTX extract.
In addition, since toxicity may be either positively or negatively
affected by impurities, at the moment it is difficult to establish
whether ovatoxins may be less powerful than palytoxin. Similarly,
it cannot be determined whether all the ovatoxin types or only
some of them have biological activity. All these aspects will be
elucidated only once it becomes possible to purify single
components in sufficient amounts to be tested in in vitro cellular
systems.
Once established that PLTX and the OSTRTX extract could
indeed promote the synthesis/accumulation of mRNAs encoding
inflammation-related proteins, we next investigated signalling
cascades possibly involved. This aspect was approached by testing
the involvement of new toxin molecular targets which mediate
immune/inflammatory reactions, such as transcription factor –kB,
and by reconsidering, in the context of inflammation, the role of
signalling mediators already known to be modulated by PLTX (i.e.
MAPKs). NF-kB resulted activated in cells exposed to PLTX and
to the OSTRTX extract via the canonical pathway which involves
reduction of IkB-a protein levels (Figure 5A) and subsequent NF-
kB nuclear translocation (Figure 6). When compared to PLTX,
the OSTRTX extract displayed totally overlapping effects on the
NF-kB pathway only at the OSTRTX dose that was effective in
accumulating inflammation-associated mRNAs in macrophages
(i.e. 20 ng/ml). Thus, although a direct relationship between
OSTRTX, particularly ovatoxins, and NF-kB activation cannot
be established, for the reasons explained above, these results
strongly suggest that these toxins may indeed engage the same
signalling pathways activated by PLTX. On the other hand, when
cells were pre-treated with an NF-kB inhibitor, which prevents
NF-kB DNA binding, the levels of all the target mRNAs, including
the IkB-a mRNA which is directly synthesized following NF-kB
activation, resulted down-regulated by 70–80% as compared to
cells receiving only PLTX or the OSTRTX extract (Figure 7).
This result provides the proof that NF-kB activation is indeed
Figure 7. Inhibition of PLTX-induced COX-2, TNF-a, and IL-8
mRNA expression upon NF-kB inhibition. Total RNA was extracted
from primary human macrophages pre-incubated 1 h with 50 mM
andrographolide, an NF-kB inhibitor molecule (iNF-kB), and then
exposed 4 h to PLTX (2 ng/ml). In parallel, macrophages were treated
with PLTX or the vehicle alone. RNA was amplified with gene-specific
primers. IkBa and UbC mRNA levels were used as positive and negative
control, respectively. Expression data, normalized to the housekeeping
B2M gene, were analysed by the 2
2DDCT method and referred to the
value obtained in untreated cells (CTR). The boxplots show the results
of 5 independent experiments. Asterisks indicate statistical significance
versus cells receiving PLTX (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0038139.g007
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(A) Western blot analysis of MAPK phosphorylation in macrophages incubated 4 h with the O. cf. ovata toxin extract (final OSTRTX concentration
2 ng/ml and 20 ng/ml) (lane 2, 3), 2 ng/ml PLTX (lane 4) or the vehicle (lane 1). 20 mg of whole cell extracts were separated by SDS-PAGE on 8% gel
and submitted to western immunoblot with phospho-specific antibodies against ERK1/2, JNK and p38 MAPK. Actin was stained as a loading control.
(B) Total RNA was extracted from macrophages pre-incubated 1 h with 1 mM p38 inhibitor (ip38) or 1 mM and 5 mM JNK inhibitor (iJNK), and then
exposed 4 h to 2 ng/ml palytoxin. In parallel, macrophages were left untreated and then exposed to PLTX or to the vehicle alone. RNA was amplified
with gene-specific primers. Expression data, normalized to the housekeeping B2M gene, were analyzed by the 2
2DDCT method and referred to the
value obtained in control cells (CTR). The boxplots show the results of 3 independent experiments, run in duplicate. Asterisks indicate statistical
significance versus cells receiving only PLTX (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0038139.g008
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signalling cascade leading to the accumulation of inflammation-
related transcripts. By contrast, no effect was observed on toxin-
induced transcriptional activation of the UbC gene. Ubiquitin C is
one of the four functional genes which encode ubiquitin (Ub) in
mammalian cells. The UbC gene is typically referred to as a stress-
inducible gene and a great bulk of literature describes the
transcriptional induction of ubiquitin upon cell challenge with
different types of stress [55]. The finding that ubiquitin is up-
regulated in PLTX- and OSTRTX-treated cells is in agreement
with previous observations in literature which demonstrate that
the cytotoxic pathway triggered by PLTX involves changes in the
cellular pool of some stress response proteins [56]. Due to the
pivotal role played by ubiquitin in many cellular processes,
including protein degradation of stress-damaged proteins, this
observation undoubtedly deserves further investigations. For
example, the Na+/K+ ATPase, which is the main target of
PLTX, has been shown to be ubiquitinated and subsequently
degraded within lysosomes under both basal and stress conditions
[57]. Thus, it could be hypothesized that induction of ubiquitin
may favor removal of toxin-‘‘damaged’’ Na+/K+ ATPase, as a
mechanism of cellular defence against PLTX toxicity. On the
other hand, it should also be considered that very preliminary
evidence, reported in this paper, indicates that palytoxin treatment
may neutralize macrophage lysosomal protease activity in intact
cells through a mechanism that is still to be defined and that could
contribute to PLTX toxicity (Figure 5B, C). On the whole, these
observations suggest that the two main cellular proteolytic systems
(i.e. the ubiquitin/proteasome and the lysosomal pathways) could
have a role in the toxic action of these marine biotoxins.
It has been well established that mitogen-activated protein
kinases can mediate palytoxin-stimulated signalling [28]. In our
experimental model, both p38 MAPK and JNK were indeed
phosphorylated upon exposure of macrophages to PLTX or to the
OSTRTX extract (Figure 8A). In the latter case differences with
respect to vehicle-treated cells were already detectable at the lower
concentration tested, although a clear accumulation of the
phospho-activated forms were observed only at the highest
OSTRTX dose (i.e. 20 ng/ml). Studies performed with chemical
inhibitors demonstrate that inhibition of p38, but not JNK,
strongly suppresses toxin-induced accumulation of inflammation-
related transcripts, thus suggesting a role for p38 in the pro-
inflammatory signalling activity of PLTX and OSTRTX/ovatox-
ins (Figure 8B). Strong down-regulation of TNF-a, IL-8 and
COX-2 mRNA expression in monocyte-derived macrophages
upon inhibition of p38 MAPK has been reported by others [58].
Indeed, in inflammatory processes, the p38 MAPK signal
transduction route regulates production and expression of
cytokines and other inflammatory mediators. In particular,
MAPKs have been widely reported to regulate gene expression
through the direct phosporylation and activation of transcription
factors, which are responsible for expression of target genes [59].
However, post-transcriptional regulation of inflammatory gene
expression has also been linked with the p38 pathway [60]. While
p38 MAPK, but not JNK, seems to participate in the toxin-
induced pro-inflammatory signalling cascade, at the moment our
data seem to exclude a role for ERK. Indeed, ERK1/2 were
constitutively phosphorylated in macrophages, in accordance with
the knowledge that they are activated by the process of adherence
[38]. Significantly, their phosphorylation state was unaffected by
toxin treatment, an observation which would exclude a role in
toxin-induced pro-inflammatory signalling. However, it has been
recently demonstrated that palytoxin also activates another
MAPK family member, called ERK5 [61]. Like other MAPKs,
ERK5 is activated by variety of stimuli, including growth factors,
G-protein-coupled receptor (GPCR) agonists, cytokines, and stress
[62]. This kinase has not been studied as extensively as the other
members of the MAPK family, but there is very preliminary
evidence which suggests a possible role in promoting inflammation
[63], [64]. Thus, further analyses will be necessary to establish
whether ERK5 participates in toxin-induced macrophage activa-
tion.
In conclusion, data reported in this paper demonstrate for the
very first time that palytoxin and, most likely, its congener
Ostreopsis cf. ovata toxins, induce a significant increase in the levels
of mRNAs encoding inflammation-related proteins in cells of the
immune system, an observation which suggest that these toxins
have the potential to exert a pro-inflammatory activity. At the
cellular level, the activity of these biotoxins is sustained by their
ability to activate both the NF-kB and the p38 MAPK signalling
pathways, although upstream molecular targets remains to be
determined and downstream effectors to be detected. On one
hand, the evidence concerning the involvement of NF-kB and p38
MAPK justifies the beneficial effects of non-steroidal anti-
inflammatory drugs (NSAIDs) and corticosteroids in patients
exposed to these toxins. Indeed, it is known that these molecules
are able to interfere with these pathways [65]–??[67]. On the other
hand, the identification of specific molecular targets of palytoxin
and its analogues, besides contributing to expand the still limited
knowledge of the intracellular signalling cascades affected by these
toxins, may have important implications in setting up more
rational and focused pharmacological interventions, replacing
currently used symptomatic treatments.
Materials and Methods
Batch culture of O. cf. ovata
The Ostreopsis cf. ovata CBA2-122 used in this study was
originally isolated from a field sample collected at Ancona, north-
western Adriatic Sea – Italy, during the autumn 2008. Cultures
were grown in 1 litre glass flasks containing 600 ml sterilized f/4
medium with an initial cell amount of 3.0610
4 cells [68]. The
temperature was set at 2361uC. Light was provided by cool white
fluorescent bulbs (photon flux of 100 mEm
22 s
21) on a standard
14 h light-10 h dark cycle. For cells enumeration, culture samples
were fixed with Lugol’s iodine and counted using the Utermho ¨l
method [69]. Cultures were harvested by centrifugation at 4,0006
g for 15 min at room temperature, and pellets were pooled in one
single sample containing approximately 3.0610
6 cells. Cell pellet
was stored at 280uC until toxin extraction.
O. cf. ovata toxin extraction and clean-up
O. cf. ovata cell pellet was extracted with 60 ml of methanol/
water (1:1 v/v) 0.2% acetic acid following the procedure
previously reported [11]. An aliquot corresponding to 75% of
the crude extract was dried under vacuum, the residue was re-
dissolved in 0.5 ml of acetonitrile/water (1:1 v/v), and subjected
to purification by semi-preparative HR LC-MS.
HR LC-MS experiments
HR LC-MS analyses were performed on an Agilent 1100 LC
binary system (Palo Alto, CA, USA) coupled to a hybrid linear ion
trap LTQ Orbitrap XL
TM Fourier transform mass spectrometer
(FTMS) equipped with an ESI ION MAX
TM source (Thermo-
Fisher, San Jose `, CA, USA). HR full MS experiments (positive
ions) were acquired in the range m/z 800–1400 at resolution
setting 30.000. The following source settings were used: spray
voltage=4 kV, capillary temperature=290uC, capillary volta-
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tube lens voltage=165 V (m/z 800–1400) or 250 V (m/z 2000–
3000). Purification of the O. cf. ovata crude extract was
accomplished on a 10 mm Gemini C18 (106250 mm i.d.) column
maintained at room temperature and eluted at 2 ml/min with
water (eluent A) and 95% acetonitrile/water (eluent B), both
containing 30 mM acetic acid. A gradient elution (20–100% B
over 40 min) and a sample injection volume of 80 ml were used.
This procedure led to obtain a semi-purified extract containing
putative palytoxin and ovatoxins (OVTX-a, -b, -c, -d + -e and –f).
Toxins contained in the semi-purified extract were quantified by
using LC conditions reported previously [11]. Extracted ion
chromatograms (XIC) were obtained from the HR full MS spectra
by selecting the most abundant peaks of the [M+2H-H2O]
2+ and
[M+H+Ca]
3+ ion clusters of each compound (Table 1). A mass
tolerance of 5 ppm was used. Peak areas were measured and
interpolated within the calibration curve of palytoxin standard
(Wako Chemicals GmbH, Neuss, Germany) at five levels of
concentrations (50, 25, 12.5, 6.25, and 3.13 ng/ml). Linearity of
the calibration curve was indicated by a correlation coefficient (R
2)
of 0.9980. In lack of standards for ovatoxins and on the base of
structural similarities between palytoxin and ovatoxins, their molar
responses were assumed to be the same as that of palytoxin.
Endotoxin content determination
Endotoxin content of palytoxin stock solutions and of the
OSTRTX extract was determined by a kinetic Limulus amoebo-
cyte lysate (LAL) assay using an Endochrome-K assay kit (Charles
River Laboratories International Inc., Wilmington, MA, USA),
according to the manufacturer’s instructions. Samples were serially
diluted from 1:50 (v/v) to 1:5000 (v/v) in LAL reagent water and
assayed in triplicate. Absorbance at 405 nm was monitored for
30 min at 2 min intervals, starting immediately after LAL reagent
addition. At the end of the monitoring interval, endotoxin activity
was calculated from a control standard endotoxin curve. Possible
interference of PLTX and of the OSTRTX extract with the LAL
enzymatic cascade was excluded by an inhibition/enhancement
test run in parallel.
Monocyte-derived human macrophages preparation and
treatment
Mononuclear cells (MCs) were isolated from Pathogen-negative
buffy coats, obtained from the Blood Transfusion Center of the
Hospital ‘‘S. Maria della Misericordia’’ – Urbino (Italy), by
separation on Lymphoprep (Axis Shield, Oslo, Norway; specific
density 1.077). Buffy coats were prepared from the blood of adult
volunteers who signed an informed consent form before donation
and samples were provided as anonymous. The use of primary
human blood cells in the context of the present study has been
approved by the research ethics committee of the University of
Urbino. MCs (12610
6 cells/well) were seeded onto 6-well plastic
culture plates (Greiner Bio-One GmbH, Frickenhausen, Germany)
and monocytes were separated from lymphocytes by adherence
overnight at 37uC as previously described [70]. After removal of
non-adhering cells by repeated washes, cells were cultured in
RPMI 1640 medium supplemented with 10% fetal bovine serum
(heat inactivated for 30 min at 56uC), 2 mM glutamine, 100 mg/
ml streptomycin, and 100 U/ml penicillin (all purchased from
Cambrex Bioscience, Verviers, Belgium), at 37uC in a 5% CO2
atmosphere. The culture medium was changed every 2 days and
after 7 days of culture the vast majority of the adherent cells were
differentiated macrophages, as revealed by immunostaining with
an anti CD14 antibody (R&D Systems Inc., Minneapolis, MN,
USA). On the 8
th–10
th day of culture, monocyte-derived
macrophages were incubated with 2 ng/ml palytoxin (Wako
Chemicals GmbH, Neuss, Germany), or with the O. cf. ovata semi-
purified toxin extract to a final OSTRTX concentration in cell
medium of 2 ng/ml and 20 ng/ml. Untreated and vehicle-treated
(i.e. 0.05%. Methanol) cells were used as controls. In some
experiments macrophages were pre-treated 1 h with the following
chemicals before toxin administration: 1 mM SB202190 (p38
inhibitor), 1 mM and 5 mM SP 600125 (JNK inhibitor) and 50 mM
andrographolide (NF-kB inhibitor), all obtained from Sigma
Aldrich (Steinheim, Germany).
RNA isolation and quantitative Real-Time PCR
Total RNA was isolated using the RNeasy (plus) mini kit
(Qiagen Inc. Valencia, CA, USA) and its concentration accurately
determined using the Nanodrop ND-1000 System (NanoDrop
Technologies, Wilmington, DE, USA). First-strand cDNA was
synthesized with the SuperScript First-Strand Synthesis System for
RT-PCR (Invitrogen, Eugene, OR, USA) and oligo-dT primers
(0.5 mg/ml) in a final volume of 20 ml, according to the
manufacturer’s instructions. The synthesized cDNAs were used
as templates in SYBR green quantitative Real-Time PCR (qRT-
PCR) assays, performed with the Hot-Rescue Real-Time PCR kit
(Diatheva s.r.l., Fano, Italy). PCR reactions were set up in a
volume of 25 ml containing 16 Hot-Rescue Real-Time Master
Mix, 0.2 mM of gene specific primers, 0.625 units of Hot-Rescue
DNA polymerase, 5 ml (0.6 ng/ml) of the RNase H-treated cDNA
stock and the MgCl2 concentration specified below for the various
targets investigated. DNA amplifications were carried out in 96-
well reaction plates using ABI PRISM 7700 Sequence Detection
System platform (Applied Biosystems, Foster City, CA, USA).
qRT-PCR primers (obtained from Sigma-Genosys Ltd, Haverhill,
UK) were designed using Primer Express version 2.0 and tested to
confirm the appropriate product size and optimal concentrations.
Primer sequences, as well as the relative MgCl2 concentration used
were: COX-2 forward, 59-CACCCATGTCAAAACCGAGG-39
and reverse, 59-CCGGTGTTGAGCAGTTTTCTC-39 (3.5 mM
MgCl2); IL-8 forward, 59-ATGACTTCCAAGCTGGCCGT-39
and reverse, 59-CAGCCCTCTTCAAAAACTTCTCC-39
(2.5 mM MgCl2); TNF-a forward, 59- GCCCAGGCAGTCA-
GATCATCTTC -39 and reverse, 59-TGCCCCTCAGCTT-
GAGGGT-39 (2.5 mM MgCl2); IkB-a forward, 59-
CGCACCTCCACTCCATCCT-39 and reverse, 59- ACATC-
CAGCCCCACACTTCAAC -39 (3.5 mM MgCl2); UbC forward,
59-GTGTCTAAGTTTCCCCTTTTAAGG-39 and reverse 59-
TTGGGAATGCAACAACTTTATTG-39 (5 mM MgCl2); b2-
microglobulin (B2M) forward, 59-GCCTGCCGTGTGAAC-
CAT-39 and reverse, 59-CATCTTCAAACCTCCATGATGCT-
39 (3.5 mM MgCl2). Cycle conditions were 95uC for 10 min
followed by 40 cycles of 15 s at 95uC, 15 s at 60uC and 30 s at
72uC. Amplification plots were analyzed using SDS 1.9.1 software
(Applied Biosystems) and relative expression data were calculated
with the 2
2DDCT method [71]. Thus, the relative abundance of the
various genes investigated, normalized to the housekeeping B2M
gene, was expressed as percent amount in cells receiving PLTX,
different concentrations of OSTRTX or the vehicle alone with
respect to the reference sample, represented by untreated cells.
Optical microscopy
Macrophages exposed 4 h to 2 ng/ml PLTX and 20 ng/ml
OSTRTX were observed with an Olympus IX51 microscope
(Olympus Corporation, Tokio, Japan). Vehicle-treated cells were
used as control. Pictures were taken at a magnification of 406
directly in culture medium without cell fixation in order to avoid
artifacts.
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Cytotoxicity was assessed by using a CellTiter-96 aqueous one
solution kit from Promega (Madison, WI, USA). This assay is
based on the reduction of the MTS reagent [3-(4,5-dimethylthia-
zol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazo-
lium, inner salt] into a colored formazan product that is soluble in
tissue culture medium. This conversion is accomplished by
NADPH or NADH produced by dehydrogenase enzymes in
metabolically active cells. The quantity of formazan product, as
measured by the absorbance at 490 nm, is directly proportional to
the number of living cells in culture.
Preparation of whole-cell lysates
For whole-cell extract preparation, macrophages were directly
harvested in SDS buffer: 50 mM Tris-HCl, pH 7.8, 0.25 M
sucrose, 2% (w/v) SDS, supplemented with a commercially
available cocktail of protease (Roche Applied Science, Indianap-
olis, IN, USA) and phosphatase (1 mM NaF, 1 mM Na3VO4)
inhibitors. Lysates were boiled for 5 min, then sonicated at 100
Watts for 20 sec. Cell debris was removed by brief centrifugation
(10 min at 12,0006 g). Protein content was determined by the
Lowry assay [72].
Nuclear-cytoplasmic subcellular fractionation
Cytosolic and nuclear extracts were obtained by low salt/
detergent cell lysis followed by high salt extraction of nuclei as
previously described [73]. After treatment, cells were extensively
washed with cold PBS and lysed with Buffer A [10 mM Hepes/
KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol
(DTT), 0.2 mM EDTA, 0.1% Nonidet-P40, supplemented with a
cocktail of protease (Roche Applied Science) and phosphatase
inhibitors]. To completely block in vitro degradation processes the
buffer was further supplemented with the following protease
inhibitors (Buffer A PLUS): 25 mg/ml leupeptin (Sigma Aldrich),
10 mg/ml pepstatin (Sigma Aldrich), 4 mM AEBSF (Roche
Applied Science), 100 mM MG-132 (Enzo Life Sciences Inc.,
NY, USA). The cell suspension was then chilled on ice for 10 min
before centrifugation at 10,0006g. The supernatant, correspond-
ing to the cytosolic fraction, was then transferred to a fresh tube,
while the resultant pellet was suspended in Buffer B [20 mM
Hepes/KOH pH 7.9, 25% glycerol, 0.42 M NaCl, 1.5 mM
MgCl2, 1 mM DTT, 0.2 mM EDTA, supplemented with the
cocktail of protease (Roche Applied Science) and phosphatase
inhibitors, 25 mg/ml leupeptin, 10 mg/ml pepstatin, 4 mM
AEBSF and 100 mM MG-132] and incubated on ice for 20 min
before being centrifuged at 10,0006 g. Nuclear extract superna-
tant was collected, diluted 1:4 in Buffer C [20 mM Hepes/KOH
pH 7.9, 20% glycerol, 50 mM KCl, 1 mM DTT, 0.2 mM EDTA,
4 mM AEBSF, 25 mg/ml leupeptin, 5 mg/ml pepstatin, 100 mM
MG-132] and stored in aliquots at 280uC until use. The resulting
pellet, containing nuclear membranes and cytoskeleton, was lysed
directly in SDS PAGE sample buffer.
Western immunoblotting
Protein extracts were resolved by SDS-PAGE and gels were
electroblotted onto a nitrocellulose membrane (0.2 mm pore size)
(BioRad laboratories Inc., Milano, Italy). The blots were probed
with the primary antibodies listed below and bands were detected
using horseradish peroxidase-conjugated secondary antibody
(BioRad Laboratories Inc.). Peroxidase activity was detected with
the enhanced chemiluminescence detection method (ECL Kit,
Amersham Biosciences, Arlington Heights, IL, USA). The
antibodies used in this study were: anti-p65 (C-20, sc-372) and
anti-IkBa (C-21, sc-371) from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA, USA); anti-actin (A 2066) from Sigma-Aldrich;
anti-Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), anti
Phospho-SAPK/JNK (Thr183/Tyr185) and anti Phospho-p38
MAPK (Thr180/Tyr182) from Cell Signaling Technology (Bev-
erly, MA, USA).
Electrophoretic Mobility Shift Assay (EMSA)
Upper strand (59-TCAACAGAGGGGACTTTCCGAGAGG-
CC-39) and reverse-complement phosphodiester oligonucleotides,
containing the NF-kB binding sequence (underlined), found in the
enhancer of the immunoglobulin light chain gene (Igk) were
custom synthesized by Thermo Fisher Scientific GmbH (Ulm,
Germany) as HPLC-purified products. As control, a double-
stranded ODN, containing the consensus sequence of the
unrelated transcription factor YY1 (59-CGCTCCGCGCCAT-
CTTGGCGGCTGGT-39) was used as competitor. The Igk
double-stranded ODN was 59 end-labeled with [c-
32P] ATP
(Perkin Elmer Inc., Waltham, MA, USA) and T4 polynucleotide
kinase (T4 PNK, Roche Applied Science). Nuclear extracts (5 mg)
were preincubated with 3 mg of double-stranded non-specific
DNA competitor poly(dI-dC) (Amersham Biosciences) for 10 min
on ice in binding buffer (20 mM Hepes-KOH, pH 7.9, 0.1 M
KCl, 5% (v/v) glycerol, 0.2 mM EGTA, 0.2 mM EDTA, 1 mM
DTT). After this time, a
32P-end-labeled DNA probe was added to
the mixtures at a final concentration of 4.4 nM and the incubation
was continued for an additional 30 min. Reaction mixtures were
then subjected to electrophoretic separation on 5% native
polyacrylamide gels (29:1 cross-linked) in Tris-glycine buffer
(25 mM Tris base, 192 mM glycine). DNA/protein complexes
were detected by exposing the dried gel in a Molecular Imager
(BioRad Laboratories Inc.). For competition experiments, nuclear
extracts were incubated with a 50-fold excess of double-stranded
competitor ODN for 10 min before adding the
32P-labeled probe.
For supershift experiments, nuclear extracts were incubated with
2 mg of anti p50 (Cell Signaling Technology), anti-p65 (C-20, sc-
372X) or anti YY1 (C-20, SC-281X) antibody (Santa Cruz
Biotechnology Inc.). Detection of NF-kB/DNA complex forma-
tion was performed in a GS-250 Molecular Imager (BioRad
Laboratories Inc.).
Statistical analysis
Statistical analysis of data was performed by ANOVA for
repeated measurement, followed by the Tukey-Kramer multiple
comparison test (for n groups .2) or with the paired t-test (for n
groups=2), using GraphPad InStat version 3.0.6 for Windows
(GraphPad Software). Differences between values were assumed
statistically significant at p,0.05 (*) and very significant at p,0.01
(**).
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